Nivatrotamab in Patients With Relapsed/Refractory Solid Tumors
Researchers are testing nivatrotamab in pediatric patients with relapsed/refractory neuroblastoma, osteosarcoma, and other GD2+ solid tumors.
Source: cancertherapyadvisor.com
📰 Shakeel Modak News
Shakeel Modak News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Shakeel Modak. Real-time updates on events, politics, business and more.
Y-mAbs Announces Naxitamab Chemoimmunotherapy
NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) --  Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
New York United States Shakeel Modak American Society Of Clinical Oncology Y Mabs Therapeutics Inc International Neuroblastoma Response Criteria
Source: globenewswire.com
CBI court acquits Chhota Rajan in 2010 double murder case due to lack of evidence
A special CBI court has acquitted Chhota Rajan in a 2010 double murder case citing lack of evidence.
Source: indiatoday.in
7th Rally for Rhyan game raises $52,000 for new MU Health Care Children's Hospital, pediatric cancer research
This years Rally for Rhyan game marks the first time that the Rally for Rhyan foundation will donate to a benefactor other than pediatric cancer research, as half of the
New York United States Memorial Sloan Kettering Cancer Center University Hospital Mun Choi Venmo Rallyforrhyan
Source: komu.com
UPDATE - Y-mAbs Announces Pipeline Update
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
New York United States Memorial Sloan Kettering Cancer Center United Kingdom Comunidad Autonoma De Cataluna Jaume Mora
Source: globenewswire.com